KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Retained Earnings (2016 - 2025)

Boston Scientific's Retained Earnings history spans 17 years, with the latest figure at -$610.0 million for Q4 2025.

  • For Q4 2025, Retained Earnings fell 122.82% year-over-year to -$610.0 million; the TTM value through Dec 2025 reached -$610.0 million, down 122.82%, while the annual FY2025 figure was -$610.0 million, 122.82% down from the prior year.
  • Retained Earnings for Q4 2025 was -$610.0 million at Boston Scientific, down from $2.7 billion in the prior quarter.
  • Across five years, Retained Earnings topped out at $2.7 billion in Q4 2024 and bottomed at -$610.0 million in Q4 2025.
  • The 5-year median for Retained Earnings is $263.0 million (2021), against an average of $511.3 million.
  • The largest annual shift saw Retained Earnings surged 687.98% in 2024 before it plummeted 122.82% in 2025.
  • A 5-year view of Retained Earnings shows it stood at $263.0 million in 2021, then increased by 2.28% to $269.0 million in 2022, then surged by 204.46% to $819.0 million in 2023, then surged by 226.37% to $2.7 billion in 2024, then tumbled by 122.82% to -$610.0 million in 2025.
  • Per Business Quant, the three most recent readings for BSX's Retained Earnings are -$610.0 million (Q4 2025), $2.7 billion (Q4 2024), and $1.6 billion (Q2 2024).